Patients blighted by a distressing skin condition that causes agonising abscesses and severe scarring have been thrown a lifeline, thanks to a drug that's just been made available on the NHS.
Secukinumab jab shows a 50 per cent reduction in symptoms of severe acnePatients blighted by a distressing skin condition that causes agonising abscesses and severe scarring have been thrown a lifeline, thanks to a drug that’s just been made available on the NHS.
Sold under the name Consentyx, the drug is taken weekly for the first month, and then every four weeks. It is only the second drug capable of tackling HS. The first, adalimumab, was approved in 2016. It is hoped secukinumab will spare many HS sufferers from requiring surgery – which is often the only option once it progresses.
‘HS can have a very big impact on the lives of patients,’ says Dr John Ingram, consultant dermatologist at Cardiff UniversityAdvertisement For reasons that are also unknown, more women than men are affected, and there is no cure. ‘The pain is often severe and patients may have to deal constantly with open wounds, which require daily dressings and can stain their clothes.‘There was no licensed treatment for this condition until recently and, for many patients, the current drug is not effective enough or became less effective over time.
Existing treatment options include antibiotics, antiseptic washes and retinoids – Vitamin A-based medicines also prescribed by specialists for patients with severe acne. If infections progress, surgery to help drain abscesses and tracts, remove build-up of scar tissue and steroid injections to reduce inflammation may be needed.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Calls for Dorset dental school to boost NHS dentist numbersIt is hoped a dental school would encourage dentists to train and then settle in Dorset.
Consulte Mais informação »
Amy Dowden reveals 2023 has been toughest year of lifeThe Strictly Come Dancing star said the ‘NHS have been incredible’ during her breast cancer treatment.
Consulte Mais informação »
New NHS warning system for parents to stop 'avoidable' child deathsThe system will ensure doctors and nurses act on parents' concerns if they feel their child is getting sicker
Consulte Mais informação »
Everolimus-eluting scaffold found better than angioplasty for CLTI patients with infrapopliteal artery diseaseA multi-institution study led by the Prince of Wales Hospital and University of New South Wales, Australia, has found that everolimus-eluting resorbable scaffold treatment leads to better outcomes than angioplasty for chronic limb-threatening ischemia (CLTI) with infrapopliteal artery disease.
Consulte Mais informação »
Hereford health centre plans aim to ease pressure at hospitalIt would be able to carry out scans on patients to check for serious diseases, an NHS trust has said.
Consulte Mais informação »
Research team finds novel drug improves outcomes for patients with rare kidney disorderFocal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure.
Consulte Mais informação »